Researchers at Stanford University have for the first time used artificial intelligence to design and create unknown synthetic viruses, marking a significant milestone in synthetic biology, with the potential to accelerate the development of treatments against antibiotic-resistant bacteria, while also raising biosafety and biosecurity concerns. (translated)




